Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage precision medicines company, is making waves in the biotechnology industry with its innovative approach to drug discovery. Based in Cambridge, Massachusetts, Relay Therapeutics..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, has caught the attention of investors with its promising pipeline and significant upside potential. Specializing in the development of novel therapeutics..
Celcuity Inc. (NASDAQ: CELC), a pioneering force in the biotechnology sector, is captivating investors with its focus on developing targeted therapies for solid tumors. Headquartered in Minneapolis, Minnesota, this clinical-stage..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a healthcare sector company specializing in biotechnology, is making waves in the biopharmaceutical industry by developing and commercializing innovative therapies for chronic endocrine and..
In the fast-evolving world of genetic medicine, MeiraGTx Holdings plc (NASDAQ: MGTX) stands out as a promising player, offering innovative treatments for serious diseases. This biotech company, focused on developing..
Bicara Therapeutics Inc. (NASDAQ: BCAX), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector with its innovative approach to cancer treatment. Based in Boston, Massachusetts, Bicara is focused..
Fortrea Holdings Inc. (FTRE) is making waves in the biotechnology sector, currently presenting investors with a tantalizing potential upside of 16.01%. As a U.S.-based contract research organization, Fortrea provides comprehensive..
In the dynamic world of cannabis and consumer products, Tilray Brands, Inc. (NASDAQ: TLRY) stands as a notable player. With its diverse portfolio and international reach, Tilray is well-positioned in..
For investors with a keen eye on the biotechnology sector, AnaptysBio, Inc. (NASDAQ: ANAB) presents an intriguing opportunity. With its focus on developing cutting-edge immunology therapeutics, AnaptysBio stands out in..
Opthea Limited (NASDAQ: OPT), a clinical-stage biopharmaceutical company, is generating buzz in the biotech industry with its innovative approach to combating eye diseases. Headquartered in Melbourne, Australia, this company operates..
Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of savvy investors with a jaw-dropping potential upside of 2,834.28%. As a clinical-stage biotechnology firm, Cel-Sci is carving its niche in the..
Emergent BioSolutions Inc. (NYSE: EBS) presents a compelling yet complex case for investors seeking opportunities in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a..
ATAI Life Sciences N.V. (NASDAQ: ATAI) is making waves in the biotechnology sector with its promising pipeline of mental health treatments and the potential for substantial stock price gains. With..
Personalis, Inc. (NASDAQ: PSNL), a prominent player in the diagnostics and research industry within the healthcare sector, is drawing significant attention from investors, fueled by a promising potential upside of..
Keros Therapeutics, Inc. (NASDAQ: KROS) is drawing significant attention in the biotechnology sector, where it is making strides with innovative therapeutics targeting disorders related to the transforming growth factor-beta family..
For investors looking to explore opportunities in the healthcare sector, Tourmaline Bio, Inc. (NASDAQ: TRML) presents a compelling case with its significant 151.69% potential upside, as reflected in current analyst..
Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector specializing in medical devices and in vitro diagnostics, presents an intriguing opportunity for investors willing to navigate its current..
Sage Therapeutics, Inc. (NASDAQ: SAGE), a player in the biopharmaceutical sector, is currently capturing attention with its significant revenue growth figure of 265.80%. Specializing in brain health medicines, Sage Therapeutics..
Investors in Tyra Biosciences, Inc. (NASDAQ: TYRA) have much to consider as the company continues to make strides in the biotechnology sector. With a current market cap of $581.24 million,..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is gaining substantial attention in the healthcare sector. Focused on developing innovative cell and exosome-based therapeutics, Capricor’s promising pipeline and strategic..
